Yuji Uehara

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Recombinant Human

Top Venues

Cancer communications (London, England)

Thoracic cancer

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Sarabjot Pabla, Jeffrey M Conroy, Paul DePietro, Heidi Ko, Jason K Sicklick, Razelle Kurzrock
4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists. Cancer communications (London, England) (2024)
Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Sarabjot Pabla, Jeffrey M Conroy, Paul DePietro, Heidi Ko, Jason K Sicklick, Razelle Kurzrock
4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists. Cancer communications (London, England) (2024)
Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy. International journal of clinical oncology (2023)
Yuji Uehara, Kageaki Watanabe, Taiki Hakozaki, Makiko Yomota, Yukio Hosomi
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations. Thoracic cancer 13 (11) (2022)